These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9211637)

  • 21. Ex vivo expansion of human cytomegalovirus-specific cytotoxic T cells by recombinant polyepitope: implications for HCMV immunotherapy.
    Rist M; Cooper L; Elkington R; Walker S; Fazou C; Tellam J; Crough T; Khanna R
    Eur J Immunol; 2005 Mar; 35(3):996-1007. PubMed ID: 15726667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation.
    Chen J; Zajac AJ; McPherson SA; Hsu HC; Yang P; Wu Q; Xu X; Wang X; Fujihashi K; Curiel DT; Mountz JD
    Gene Ther; 2005 Jul; 12(13):1079-88. PubMed ID: 15815704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.
    Liu L; Flaño E; Usherwood EJ; Surman S; Blackman MA; Woodland DL
    J Immunol; 1999 Jul; 163(2):868-74. PubMed ID: 10395681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced generation of cytotoxic T lymphocytes by increased cytosolic delivery of MHC class I epitope fused to mouse heat shock protein 70 via polyhistidine conjugation.
    Takemoto S; Nishikawa M; Otsuki T; Yamaoka A; Maeda K; Ota A; Takakura Y
    J Control Release; 2009 Apr; 135(1):11-8. PubMed ID: 19100299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evasion of cytotoxic T lymphocytes by murine cytomegalovirus.
    Kavanagh DG; Hill AB
    Semin Immunol; 2001 Feb; 13(1):19-26. PubMed ID: 11289796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.
    Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA
    Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells spill the beans.
    Watts C
    Nat Cell Biol; 1999 Oct; 1(6):E152-4. PubMed ID: 10559977
    [No Abstract]   [Full Text] [Related]  

  • 28. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
    Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
    Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.
    Laus R; Graddis TJ; Hakim I; Vidovic D
    Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling and cross-presentation.
    Heath WR; Carbone FR
    Nature; 2005 Mar; 434(7029):27-8. PubMed ID: 15744280
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interactions of some viruses with peritoneal macrophages].
    Suptel' EA; Maksimovich NA
    Dokl Akad Nauk SSSR; 1971 Feb; 196(4):959-61. PubMed ID: 4325126
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytotoxic T cells and human herpes virus infections.
    Borysiewicz LK; Sissons JG
    Curr Top Microbiol Immunol; 1994; 189():123-50. PubMed ID: 7924434
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional testing of a bicistronic retroviral vector for intracellular peptide production.
    Duch M; Tolstrup A; Dalum I; Jespersen T; Mouritsen S; Pedersen FS
    Biotechniques; 1999 Jun; 26(6):1032-4, 1036. PubMed ID: 10376133
    [No Abstract]   [Full Text] [Related]  

  • 34. [Herpesvirus infection].
    Yasukawa M
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():495-502. PubMed ID: 15861701
    [No Abstract]   [Full Text] [Related]  

  • 35. [Double infections due to herpesviruses and adenoviruses in infants' communities].
    Holý J; Vanĕcek K
    Cesk Pediatr; 1974 Apr; 29(4):182-5. PubMed ID: 4364570
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of interference with the MHC class I-restricted pathway of antigen presentation by herpesviruses.
    Hill AB
    Immunol Cell Biol; 1996 Dec; 74(6):523-6. PubMed ID: 8989590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic T lymphocytes in herpesvirus infections.
    Rouse BT; Horohov DW
    Vet Immunol Immunopathol; 1984 May; 6(1-2):35-66. PubMed ID: 6330966
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the conversion rates to Adenoviruses and Herpesviruses in an infants' community (author's transl)].
    Holý J; Vanĕcek K; Pavlík Z
    Cesk Epidemiol Mikrobiol Imunol; 1975 Jan; 24(1):15-21. PubMed ID: 165903
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of the reticuloendothelial system in the development of some experimental virus infections].
    Maksimovich NA; Suptel' EA
    Dokl Akad Nauk SSSR; 1971 Jan; 196(2):451-4. PubMed ID: 4324724
    [No Abstract]   [Full Text] [Related]  

  • 40. Antagonists or altruists: do viral mutants modulate T-cell responses?
    Davenport MP
    Immunol Today; 1995 Sep; 16(9):432-6. PubMed ID: 7546207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.